Study of Maraviroc (MVC) and Epzicom (ABC/3TC) Once-Daily in ART-Naive & First Switch Patients
Condition: Drug-induced HypotensionIntervention: Sponsors: Nicholaos C Bellos, MD; GlaxoSmithKlineCompleted - verified December 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2015 Category: Research Source Type: clinical trials